Elanco Animal Health Incorporated Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year
Elanco Animal Health Incorporated (ELAN) had Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year of $14.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear · last filed 2026-02-24
- 2025-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year $14.00M.
- 2024-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year $11.00M.
- 2023-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year $10.00M.
| Period end | Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year |
|---|---|
| 2025-12-31 | $14.00M 10-K · filed 2026-02-24 |
| 2024-12-31 | $11.00M 10-K · filed 2025-02-25 |
| 2023-12-31 | $10.00M 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |